EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a High‐Throughput LC–MS/MS Method for Simultaneous Quantification of Four Therapeutic Monoclonal Antibodies in Human Serum: Application in Clinical Therapeutic Drug Monitoring

Yuan Yao iD, Guang-Yao Huang, Ting-Ting Wu, Ting-Fei Tan, Feng-Mei Hu, Chao Huang, Shan Gao iD, An-Ping Guo iD, Jun-Ping Wang iD

Biomedical Chromatography · 2026

DOI: 10.1002/bmc.70350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2026. Verfasst von Yuan Yao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei Cancer Hospital, Hefei, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Liquid Chromatography-Mass Spectrometry, Drug Monitoring, Antibodies, Monoclonal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: President's Fund of Hefei Institutes of Physical Science, Chinese Academy of Sciences, Anhui Province Health Research Project, Open Fund of Anhui Provincial Key Laboratory of Precision Pharmaceutical Preparations and Clinical Pharmacy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monoclonal antibody (mAb) therapies have revolutionized cancer treatment, significantly improving patient outcomes. However, the pharmacokinetics (PK) and pharmacodynamics (PD) of mAbs exhibit considerable variability due to nonlinear kinetics and individual differences, highlighting the need for therapeutic drug monitoring (TDM). Therefore, this study aimed to develop and validate a reliable LC–MS/MS method for the simultaneous quantification of bevacizumab, trastuzumab, rituximab, and pertuzumab in human serum and evaluate its clinical applicability. Characteristic peptides were identified using Skyline. Serum samples underwent Protein G purification and trypsin digestion. Separation used a C18 column with 0.1% FA and acetonitrile, and detection employed multiple reaction monitoring with cadonilimab as the internal standard. The method demonstrated excellent linearity (1–200 μg/mL), precision (CV < 8.9%), and accuracy (±9.8%). With a runtime of 12 min, the validated method requires only 10 μL of serum per sample and meets international validation standards, supporting the clinical monitoring of these therapies. A robust, cost‐effective, and high‐throughput LC–MS/MS method was successfully developed for the simultaneous quantification of four therapeutic mAbs. The method significantly reduces sample volume and analysis time while maintaining high accuracy and reproducibility, making it well‐suited for routine TDM and broader clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryLiquid Chromatography-Mass SpectrometryDrug MonitoringAntibodies, MonoclonalHumansReproducibility of ResultsLinear ModelsLimit of Detection

Stichwörter der Autor:innen

bevacizumabliquid chromatography–tandem mass spectrometrypertuzumabrituximabtrastuzumab

Substanzen

Antibodies, Monoclonal

Autor:innen und Institutionen

  • Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei Cancer Hospital, Hefei, China.
  • Shanghai AB Sciex Analytical Instrument Trading Co. Ltd., Shanghai, China.
  • Department of Pharmacology, Basic Medical College, Anhui Medical University, Hefei, China.
  • Department of Pharmacy, The First Affiliated Hospital of University of Science and Technology of China. Anhui Provincial Hospital, Hefei, China.

ORCID-Profile: Yuan Yao, Shan Gao, An-Ping Guo, Jun-Ping Wang

Förderung

  • President's Fund of Hefei Institutes of Physical Science, Chinese Academy of Sciences
  • Anhui Province Health Research Project
  • Open Fund of Anhui Provincial Key Laboratory of Precision Pharmaceutical Preparations and Clinical Pharmacy

Zitieren

APA

Yao, Y., Huang, G. Y., Wu, T. T., Tan, T. F., Hu, F. M., Huang, C., Gao, S., Guo, A. P., & Wang, J. P. (2026). Development of a High‐Throughput LC–MS/MS Method for Simultaneous Quantification of Four Therapeutic Monoclonal Antibodies in Human Serum: Application in Clinical Therapeutic Drug Monitoring. Biomedical Chromatography. https://doi.org/10.1002/bmc.70350

Vancouver

Yao Y, Huang GY, Wu TT, Tan TF, Hu FM, Huang C, et al. Development of a High‐Throughput LC–MS/MS Method for Simultaneous Quantification of Four Therapeutic Monoclonal Antibodies in Human Serum: Application in Clinical Therapeutic Drug Monitoring. Biomedical Chromatography. 2026. doi:10.1002/bmc.70350

BibTeX
@article{Yao2026,
  author = {Yao, Yuan and Huang, Guang-Yao and Wu, Ting-Ting and Tan, Ting-Fei and Hu, Feng-Mei and Huang, Chao and Gao, Shan and Guo, An-Ping and Wang, Jun-Ping},
  title = {Development of a High‐Throughput LC–MS/MS Method for Simultaneous Quantification of Four Therapeutic Monoclonal Antibodies in Human Serum: Application in Clinical Therapeutic Drug Monitoring},
  journal = {Biomedical Chromatography},
  year = {2026},
  doi = {10.1002/bmc.70350}
}
Kostenlos starten →